Table 1. Clopidogrel treatment prolonged bleeding time without any effect on lipid and blood pressure.
Item | Saline(n = 5) | AngII(n = 11) | AngII+Clog(n = 13) | p | |
Lipid fractions, mg/dL | Total cholesterol | 782.3±48.6 | 836.2±54.1 | 789.9±69.7 | NS |
Triglycerides | 188.4±32.7 | 188.8±36.9 | 177.2±15.4 | NS | |
Systolic blood pressure, mm Hg | Before treatment | 105.7±6.2 | 106.3±8.3 | 105.5±5.9 | NS |
After infusion | 104.4±6.9 | 150.4±9.7† | 149.3±10† | P<0.05 | |
Bleeding time,second | 116.8±31.6 | 108.9±22.3 | >900* | P<0.05 | |
AAA formation, n (%) | None | 8 (66.7) | 3 (20.0)* | P<0.05 | |
AAA rupture, n (%) | None | 5 (62.5) | 2 (66.7) | NS |
Effect of clopidogrel and angiotensin II (Ang II) on lipid levels, systolic blood pressure and bleeding time in apolipoprotein E (ApoE)-knockout mice.
P<0.05 compared with saline infusion or before treatment.
P<0.05 compared with control or Ang II-treated only mice.
NS, no significant difference.
Results are mean ± SD.